Introduction
============

*Ficus carica* (fig) is an important member of the family Moraceae, which has been cultivated by humans for a long time. *F. carica* is originally from the Middle East and West Asia, but spread to many other regions in the world. Products of *F. carica* are widely used as food sources and medicine to treat various diseases.[@b1-ott-11-4377] For example, extract of fig fruit exerts hypotensive and antihypertensive effects in glucose-induced hypertensive rats[@b2-ott-11-4377] and exhibits moderate cytotoxic activities against human cancer cell lines, eg, MCF7, HepG2, and U2OS,[@b3-ott-11-4377] and exhibits antiproliferation against cervical cancer cell lines.[@b4-ott-11-4377] Leaf decoctions affect lipid catabolism in hypertriglyceridemic rats and had hypoglycemic action in type 1 diabetic patients, while fig latex also shows in vitro inhibitory effects on proliferation of various cancer cell lines.[@b5-ott-11-4377]--[@b7-ott-11-4377]

Fig leaves, fruit, and latex all contain anticancer components, among which bergapten and psoralen are two important ones.[@b8-ott-11-4377] Bergapten has inhibitory effects on the liver cancer cell line, stomach cancer cell line, and NPC cells, the mechanism of which may include direct killing, arresting the cell cycle, and inducing apoptosis.[@b9-ott-11-4377],[@b10-ott-11-4377] It has been proved that psoralen can inhibit the proliferation and migration abilities of MCF7/ADR cells,[@b11-ott-11-4377] as well as inhibit breast cancer-cell growth in the bone microenvironment and regulate the function of osteoblasts and osteoclasts in tumor-bearing mice.[@b12-ott-11-4377]

Breast cancer has substantially higher incidence than any other cancer among diseases in women,[@b13-ott-11-4377] and are categorized into three basic groups: estrogen receptor (ER) positive, human epidermal growth factor receptor-2 (HER2/ERBB2) and triple-negative breast cancer (TNBC, also known as basal-like breast cancer). TNBC is the most difficult subtype of breast cancer to treat. Some key molecules in breast cancer are tightly involved in proliferation or apoptosis of breast cancer cells, including *GATA3, p53, Bax, p21, ELF5*, and cyclin-dependent kinases *(CDKs)*, which can affect the viability of cancer cells by influencing the cell cycle, repairing damaged DNA, or inducing apoptosis.[@b14-ott-11-4377]--[@b16-ott-11-4377] Metastasis is the main cause of death caused by breast cancer, and many molecules are involved in the process, including *MPP2, TIMP1*, and *TIMP2*.[@b17-ott-11-4377]--[@b19-ott-11-4377] In this study, we explored whether extracts from *F. carica* leaves and their bergapten and psoralen components have anticancer effects on TNBC cell line MDA-MB-231, and investigated the molecular mechanisms underlying this effect by analyzing the expression of key breast cancer biomarkers crucial to cell proliferation, the cell cycle, and migration.

Materials and methods
=====================

Materials and reagents
----------------------

*F. carica* leaves were collected from Jilin Agriculture University in September 2017 and taxonomically confirmed by Professor Yaohui Hu at the School of Food Science and Engineering. 40 g fig leaves was macerated in 450 mL water at 25°C for 1 hour, and boiled for 2 hours in distillation apparatus. The extract of fig leaves was concentrated to 50 mL, and filtered through a 0.22 μm filter. To calculate the concentration of the extract of fig leaves, the residue of fig leaves was dried and weighed, and totally 20 g of the residue of fig leaves was obtained. Therefore, the concentration of the extract was calculated as following, (40 g--20 g)/50 mL = 400 mg/mL. Psoralen (66-97-7; Meilun Biotechnology, Dalian, China), bergapten (484-20-8; Meilun Biotechnology), an MTT cell-proliferation and cytotoxicity-assay kit (BB-4201; BestBio, Shanghai, China), cell-cycle-detection kit (BB4104; BestBio, Nanjing, China), Trizol Plus RNA-purification kit (12183555; Thermo Fisher Scientific, Waltham, MA, USA), Super RT kit (PR-6601; BioTek, Winooski, VT, USA), and SYBR reverse-transcription polymerase chain reaction (RT-PCR) premixture (PR7701; BioTek) were used in this study.

Cell culture
------------

The human breast epithelial cell line MCF-10A and human breast cancer cell line MDA-MB-231 were a generous gift from Professor Zhe Li (Harvard University, Boston, MA, USA). Use of the gifted MCF-10A and MDA-MB-231 cells was approved by the School of Life Sciences, Jilin University, Changchun, China. MCF-10A cells were cultured with Ham's F12 medium and DMEM with 2.5 mM L-glutamine (Thermo Fisher Scientific) and supplemented with 5% horse serum (Thermo Fisher Scientific), 0.5 mg/mL hydrocortisone (Sigma-Aldrich, St Louis, MO, USA), 100 ng/mL cholera toxin (Sigma-Aldrich), 20 ng/mL epidermal growth factor (PeproTech, Rocky Hill, NJ, USA), 10 μg/mL insulin (Sigma-Aldrich), and 100 IU/mL penicillin--streptomycin (Sigma-Aldrich). MDA-MB-231 cells were cultured with DMEM (Thermo Fisher Scientific) supplemented with 10% FBS (Thermo Fisher Scientific) and 100 IU/mL penicillin--streptomycin (Sigma-Aldrich). The culture environment was maintained at 37°C with saturated humidity and 5% CO~2~.

MTT assays
----------

Cells were seeded at 5,000/well in a 96-well plate and incubated in media with different concentrations of *F. carica* leaf extract, psoralen, and bergapten for 24, 48, and 72 hours, respectively. The effect of *F. carica* on cell viability was assessed by MTT (BestBio) solution. After incubation for each period, 10 μL MTT solution (5 mg/mL) was added to each well and incubated for 4 hours at 37°C. Then, the medium was removed and replaced by 150 μL dimethyl sulfoxide (BestBio). Plates were read at 490 nm wavelength using a microplate reader (ELx808; BioTek). All experiments were repeated three times.

Wound-healing assays
--------------------

MDA-MB-231 cells were seeded in six-well plates at a density such that after 24 hours of incubation, they reached about 90% confluence as a monolayer. A wound was generated by scratching the monolayer with a 200 μL pipette tip across the center of the well. After scratching, wells were gently washed twice to remove the detached cells and replaced with fresh DMEM (without serum). These MDA-MB-231 cells were treated with various graded concentrations of *F. carica* leaf extract, psoralen, and bergapten. Microscopy images were taken at indicated time points 0, 24, and 48 hours to measure the width of the gaps. Widths of gaps were quantified and analyzed with Image-Pro Plus 6.0 software (Media Cybernetics, Bethesda, MD, USA). Nine duplicate photos were taken for each treatment. All experiments were repeated three times. The average wound size represented relative cell migration.

Cell-cycle analysis
-------------------

MDA-MB-231 cells were exposed to graded concentrations of *F. carica* leaf decoction (0, 4 mg/mL) for 48 or 72 hours and collected. Cell-cycle distribution was evaluated using the cell-cycle-detection kit according to the manufacturer's instructions. Briefly, cells were washed twice with cold PBS and fixed in 70% ethanol at −20°C overnight. Cells were resuspended in cold PBS containing 1% BSA and 20 μL RNase incubated at 37°C for 30 minutes, and then stained with a propidium iodide solution at 4°C for 30 minutes. Cell cycles were analyzed by flow cytometry (FACScan; BD, Franklin Lakes, NJ, USA). Cell-cycle distribution was calculated using ModFit cell-cycle-analysis software (version 2.01.2; BD).

Quantitative RT-PCR
-------------------

MDA-MB-231 cells were treated with graded concentrations of an *F. carica* leaf decoction (0, 4, 8 mg/mL) for 48 or 72 hours and collected. RNA isolation and quantitative RT-PCR (qRT-PCR) assays were performed according to the manufacturer's instructions. Total RNA from cells was extracted with Trizol reagent following the manufacturer's protocol, and complementary DNA was synthesized using Moloney murine leukemia virus (M-MLV) RT with random primers. Complementary DNA was generated with the Super RT kit according to the manufacturer's protocol. qRT-PCR was performed using the SYBR RT-PCR premixture. qRT-PCR primer sequences are listed in [Table 1](#t1-ott-11-4377){ref-type="table"}.

Statistical analysis
--------------------

All data analyses were performed with SPSS 18.0 software (SPSS, Chicago, IL, USA). Results are reported as mean ± SD of at least three independent experiments. Student's *t*-test was used to compare differences between two groups. Tukey's post hoc test was used to validate the ANOVA for comparing measurement data between groups. *P*\<0.05 was considered statistically significant.

Results
=======

Treatment with extracts and components of *F. carica* leaves inhibited proliferation of MDA-MB-231 cells, but not MCF10A cells
------------------------------------------------------------------------------------------------------------------------------

To investigate the anticancer effects of extracts and components of *F. carica* leaves, MTT assays were performed to evaluate the proliferation of the breast cancer cell line MDA-MB-231 and normal breast epithelial cell line MCF10A. MDA-MB-231 and MCF10A cells were incubated with different concentrations of an aqueous extract of *F. carica* leaves. Analysis indicated that the *F. carica* leave extract treatment decrease the viability of the MDA-MB-231 cell in a dose- and time-dependent manner ([Figure 1A](#f1-ott-11-4377){ref-type="fig"}), but did not have any effect on the viability of normal epithelial MCF10A cells ([Figure 1B](#f1-ott-11-4377){ref-type="fig"}), demonstrating that the antiproliferation effect of *F. carica* leaf extract was specific to MDA-MB-231 cells. To verify further the observation of the antiproliferation effect of *F. carica* leaves, MDA-MB-231 cells were treated with psoralen ([Figure 1C](#f1-ott-11-4377){ref-type="fig"}) and bergapten ([Figure 1D](#f1-ott-11-4377){ref-type="fig"}), two major active components of *F. carica* leaves. Treatment with psoralen and bergapten reduced the viability of MDA-MB-231 cells ([Figure 1E and F](#f1-ott-11-4377){ref-type="fig"}), but not the viability of MCF10A cells ([Figure S1](#SD1-ott-11-4377){ref-type="supplementary-material"}).

Treatment with extracts and components of *F. carica* suppressed expression of key genes involved in the regulation of cell viability
-------------------------------------------------------------------------------------------------------------------------------------

To investigate the mechanism underlying the inhibitory effects of *F. carica* leaf extract on the proliferation of MDA-MB-231 cells, the expression of genes involved in proliferation and antiapoptosis was examined. *F. carica* leaf-extract treatment increased the expression levels of *BAX*, *TP53*, and *TP21* ([Figure 2A and B](#f2-ott-11-4377){ref-type="fig"}), which were involved in the promotion of apoptosis and regulation of cell viability, supporting the possibility that the inhibitory effects on cell viability might be caused by the promotion of apoptosis. Furthermore, the activation of proteins that were involved in the regulation of apoptosis was examined by Western blotting, and caspase 3 was cleaved upon treatment with extracts of *F. carica* leaves ([Figure S2](#SD1-ott-11-4377){ref-type="supplementary-material"}). In addition, the expressions of the breast cancer-marker gene *GATA3* and proto-oncogene *ELF5* were also examined by RT-PCR. The results showed that the mRNA level of *GATA3* was decreased, while the expression of *ELF5* was increased upon treatment ([Figure 2C and D](#f2-ott-11-4377){ref-type="fig"}). These observations suggest the antitumor proliferation effect of *F. carica* leaves might be caused by the decreased expression of the breast cancer-marker gene *GATA3*.

Extract of *F. carica* leaves induced cell-cycle arrest in MDA-MB-231 cells at the Sphase
-----------------------------------------------------------------------------------------

To clarify the mechanism of how *F. carica* leaf extract inhibited the growth of MDA-MB-231 cells, flow cytometry was performed to examine the effect of *F. carica* leaf extract on the cell cycle. We found that the percentage of MDA-MB-231 cells in the S phase was significantly increased upon *F. carica* leaf treatment ([Figure 3A and B](#f3-ott-11-4377){ref-type="fig"}). Meanwhile, CDK-family protein transcription, which is involved in cell-cycle arrest, was also detected by RT-PCR. The results showed that mRNA levels of the CDK family were downregulated upon treatment with *F. carica* leaves ([Figure 3C and D](#f3-ott-11-4377){ref-type="fig"}). These results demonstrated that *F. carica* leaf extract can induce cell-cycle arrest in MDA-MB-231 cells at the S phase, maybe partly through inhibiting the expression of genes in the CDK family.

Aqueous extract of *F. carica* leaves and its major active components suppressed migration of MDA-MB-231 cells
--------------------------------------------------------------------------------------------------------------

To investigate further the antitumor effects of *F. carica* leaf extract, we conducted wound-healing assays to examine whether the treatment with *F. carica* leaf extract could affect the migration of MDA-MB-231 cells. The results showed that migration of MDA-MB-231 cells was significantly reduced by treatment with *F. carica* leaf extract ([Figure 4A and B](#f4-ott-11-4377){ref-type="fig"}). Moreover, expressions of genes involved in cell migration were examined by RT-PCR. We found that expression of *MPP2*, a gene involved in promotion of migration, was significantly decreased upon *F. carica* leaf treatment. On the other hand, the expressions of genes involved in suppression of migration, eg, *TIMP1* and *TIMP2*, were increased upon *F. carica* leaf treatment ([Figure 4C](#f4-ott-11-4377){ref-type="fig"}). The effects of psoralen and bergapten on the mobility of MDA-MB-231 cells were consistent on wound-healing assays: both suppressed the migration of MDA-MB-231 cells ([Figure 4D--G](#f4-ott-11-4377){ref-type="fig"}).

Discussion
==========

In this study, we report that treatment with *F. carica* extract inhibits the proliferation of MDA-MB-231 cells, but not MCF10A cells. MDA-MB-231 is a TNBC cell line, and MCF10A is a normal breast epithelial cell line. This result suggests that extracts and components of *F. carica* have specific growth-inhibitory effects on breast cancer cells. In agreement with our result, previous studies have found that fig leaves, fruit, and latex all contain anticancer components.[@b3-ott-11-4377]--[@b8-ott-11-4377]

Previous studies have shown that of fig fruit extracts exhibited moderate cytotoxic activities against MCF7, HepG2, and U2OS cells,[@b3-ott-11-4377],[@b4-ott-11-4377] and fig latex has also shown inhibitory effects on proliferation of various cancer cell lines, eg, the Raji B-cell lymphoma stomach cancer line.[@b5-ott-11-4377]--[@b7-ott-11-4377] Little was known about the antiproliferation effect of the leaf decoction in cancer. We found that of *F. carica* leaf extract had an antiproliferation effect on TNBC cell MDA-MB-231 and could upregulate the expression of genes involved in apoptosis, such as *BAX*, *TP53*, and *TP21*. Moreover, we also found that *F. carica* leaf decoction perhaps inhibited the viability of MDA-MB-231 cells partly by enhancing cell-cycle arrest in the S phase. Consistently with the role of CDKs in the cell cycle,[@b15-ott-11-4377] our results also demonstrated mRNA levels of *CDK1*, *CDK5*, *CDK9*, and *CDK10* were down-regulated upon treatment with *F. carica* leaves. Additionally, we demonstrated that *F. carica* leaves and the plant's major components psoralen and bergapten significantly inhibited the migration ability of MDA-MB-231. Consistently with suppressed migration, our results showed an increased expression level of *MPP2* and decreased expression level of *TIMP1* and *TIMP2*. To summarize, *F. carica L* leaves have multiple anticancer effects on breast cancer.

*F. carica* products have been widely used as both food and medicine, and the plant's use in multiple cancer prevention, cancer therapy, and anti-inflammation may even have originated in ancient and medieval times.[@b19-ott-11-4377] Previous research has also shown that *F. carica* products can inhibit proliferation of various cancer cell lines, such as cervical cancer cell line HeLa. Fig products contain anticancer components, such as bergapten, psoralen, benzaldehyde, amylose, and selenium.[@b8-ott-11-4377]

Although the present study provided some interesting results, there were also a few limitations. First, we did not employ high-enough concentrations of psoralen and ber-gapten find IC~50~ levels, since these substances are difficult to dissolve, even in dimethyl sulfoxide. Second, cell-cycle analysis has not been done for the compounds, which will be performed in the following study. In conclusion, extracts of *F. carica* leaves showed anticancer effects in TNBC cells, and thus might be a potential source to develop cancer medicine.

Supplementary materials
=======================

###### 

Psoralen and bergapten did not affect the survival of the normal mammary epithelial cell line MCF10A.

**Notes:** MCF10A cells were treated with different concentrations of (**A**) psoralen (0, 20, 40, 60, 80, 100 μg/mL) and (**B**) bergapten (0, 5, 15, 20, 25, 30 μg/mL) at different time points (24, 48, 72 hours). Viability of treated cells evaluated by MTT assays. Viability of control cells at 24 hours represented as 100%. Data presented as mean ± SD (n=3).

###### 

Extracts of *Ficus carica* leaves affect the activation of proteins involved in the regulation of apoptosis.

**Notes:** MDA-MB-231 cells were treated with different concentrations of extracts of *F. carica* leaves (0, 4, 8 mg/mL) for 72 hours. Protein levels of key apoptosis markers measured by Western blotting with antibodies indicated.
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![Extracts of *Ficus carica* leaves, psoralen, and bergapten inhibited the proliferation of MDA-MB-231 cells.\
**Notes:** (**A**) MDA-MB-231 and (**B**) MCF10A cells were treated with extracts of *F. carica* leaves (0, 1, 2, 4, 8 mg/mL) at different time points (24, 48, 72 hours). Viability of treated cells evaluated by MTT assays. (**C**) Chemical structure of psoralen. (**D**) Chemical structure of bergapten. (**E**) MDA-MB-231 cells were treated with different concentrations of psoralen (0, 20, 40, 60, 80, 100 μg/mL) and (**F**) bergapten (0, 5, 10, 15, 20, 25, 30 μg/mL) at different time points (24 hours, 48 hours, 72 hours). Viability of treated cells evaluated by MTT assays. Viability of control cells at 24 hours represented as 100%. Data presented as mean ± SD (n=3). \**P*\<0.01; \*\**P*\<0.05; \*\*\**P*\<0.001.](ott-11-4377Fig1){#f1-ott-11-4377}

![Extracts of *Ficus carica* leaves affected the expression of genes that regulate cell viability.\
**Notes:** (**A**, **B**) MDA-MB-231 cells were treated with different concentrations of extracts of *F. carica* leaves (0, 4, 8 mg/mL) at different time points (48, 72 hours). Expression of key genes involved in regulation of cell viability measured by quantitative polymerase chain reaction. (**C**, **D**) MDA-MB-231 cells were treated with different concentrations of extracts of *F. carica* leaves (0, 4, 8 mg/mL) at different time points (48, 72 hours). Expression of key genes of breast cancer biomarkers measured by quantitative polymerase chain reaction. Data presented as mean ± SD (n=3). \**P*\<0.01; \*\**P*\<0.05; \*\*\**P*\<0.001.](ott-11-4377Fig2){#f2-ott-11-4377}

![Extracts of *Ficus carica* leaves induced cell-cycle arrest.\
**Notes:** (**A**) Cells were incubated with extracts of *F. carica* leaves at concentrations of 0 or 4 mg/mL for 48 hours or 72 hours, stained with propidium iodide, and numbers of cells at different phases of cell cycle analyzed by flow cytometry. (**B**) Percentage of cells at different phases of cell cycle shown. Reverse-transcription polymerase chain-reaction analysis showed decreased expression of genes in CDK family in MDA-MB-231 upon treatment with extracts of *F. carica* leaves for 48 hours (**C**) or 72 hours (**D**). Data presented mean ± SD (n=3). \**P*\<0.01; \*\**P*\<0.05.](ott-11-4377Fig3){#f3-ott-11-4377}

###### 

Extracts of *Ficus carica* leaves, psoralen, and bergapten suppressed migration of MDA-MB-231 cells.

**Notes:** (**A**) MDA-MB-231 cells were treated with 1 mg/mL extracts of *F*. carica leaves and mobility of MDA-MB-231 cells evaluated by wound-healing assays. After treatment for indicated times (0, 24, or 48 hours), cell migration in the denuded zone was photographed. Representative images of migrated cells shown. Scale bars represent 100 μm (**B**) Relative migration of the treated MDA-MB-231 cells was analyzed. Data presented as mean ± SD (n=9, \*\*\**P*\<0.001). (**C**) MDA-MB-231 cells were treated with 2 or 8 mg/mL extracts of *F. carica* leaves for 48 hours and expression levels of MMP2, TIMP1, and TIMP2 measured by reverse-transcription polymerase chain reaction. Data presented as mean ± SD (n=3, \**P*\<0.05, \*\**P*\<0.01, \*\*\**P*\<0.001). (**D**) MDA-MB-231 cells were treated with 20 μg/mL psoralen for indicated time points (0, 24, or 48 hours), and cell migration in the denuded zone was photographed. Representative images of migrated cells are shown. Scale bars represent 100 μm (**E**) Relative migration level of psoralen-treated MDA-MB-231 cells was analyzed. Data presented as mean ± SD (n=9, \**P*\<0.05, \*\**P*\<0.01). (**F**) MDA-MB-231 cells were treated with 5 μg/mL bergapten for indicated times (0, 24, or 48 hours) and cell migration in the denuded zone photographed. Representative images of migrated cells are shown. Scale bars represent 100 μm (**G**) Relative migration level of bergapten-treated MDA-MB-231 cells was analyzed. Data presented as mean ± SD (n=9, \**P*\<0.05).
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###### 

Quantitative RT-PCR primer sequences (all sequences from 5′ to 3′)

  Gene      Forward                  Reverse
  --------- ------------------------ --------------------------
  β-actin   GCCGCCAGCTCACCAT         TCGATGGGGTACTTCAGGGT
  Bax       CCCTTTTGCTTCAGGGTTTC     CCCTTTTGCTTCAGGGTTTC
  p53       CCTCAGCATCTTATCCGAGTGG   TGGATGGTGGTACAGTCAGAGC
  p21       GTGAGCGATGGAACTTCGACTT   AGAGGTTTACAGTCTAGGTGGA
  GATA3     GCCGTTGAGGGTTTCAGAGA     TCCGAGCACAACCACCTTAG
  ELF5      CTCTTTGGACCTAGCCACCG     AGCAGTTGGAATCAGCATCTGT
  CDK1      CTGGCTGATTTTGGCCTTGC     CCACTTCTGGCCACACTTCA
  CDK5      CTCCGGGAGATCTGCCTACT     AGCTCCCCATTCTTTACAATCTCA
  CDK9      CAGTACGACTCGGTGGAGTG     TGTAATGGGGAACCCCTCCT
  CDK10     TGGACAAGGAGAAGGATG       CTGCTCACAGTAACCCATC
  MMP2      GAGTGCATGAACCAACCAGC     GTGTTCAGGTATTGCATGTGCT
  TIMP1     GCAATTCCGACCTCGTCATC     TAGACGAACCGGATGTCAGC
  TIMP2     CTGCGAGTGCAAGATCACG      TGGTGCCCGTTGATGTTCTT

**Abbreviation:** RT-PCR, reverse-transcription polymerase chain reaction.
